A Phase IV, multicenter, randomized, open label trial to evaluate the effectiveness of inclisiran + usual care vs usual care alone as a tool to close care gaps within a pragmatic framework in an inclusive and underrepresented population at high risk for or diagnosed with ASCVD.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Matthew Cavender
Medicine - Cardiology
Clinical or Medical
Interventional
Heart and Circulation
24-1900
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
